|
1
|
Yeasmin S, Nakayama K, Rahman MT, Rahman
M, Ishikawa M, Katagiri A, Iida K, Nakayama N, Otuski Y, Kobayashi
H, et al: Biological and clinical significance of NAC1 expression
in cervical carcinomas: A comparative study between squamous cell
carcinomas and adenocarcinomas/adenosquamous carcinomas. Hum
Pathol. 43:506–519. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith HO, Tiffany MF, Qualls CR and Key
CR: The rising incidence of adenocarcinoma relative to squamous
cell carcinoma of the uterine cervix in the United States-a 24-year
population-based study. Gynecol Oncol. 78:97–105. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chan PG, Sung HY and Sawaya GF: Changes in
cervical cancer incidence after three decades of screening US women
less than 30 years old. Obstet Gynecol. 102:765–773. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu S, Semenciw R and Mao Y: Cervical
cancer: The increasing incidence of adenocarcinoma and
adenosquamous carcinoma in younger women. CMAJ. 164:1151–1152.
2001.PubMed/NCBI
|
|
5
|
Wright AA, Howitt BE, Myers AP, Dahlberg
SE, Palescandolo E, Van Hummelen P, MacConaill LE, Shoni M, Wagle
N, Jones RT, et al: Oncogenic mutations in cervical cancer: Genomic
differences between adenocarcinomas and squamous cell carcinomas of
the cervix. Cancer. 119:3776–3783. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vivanco I and Sawyer CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chang L, Graham PH, Hao J, Ni J, Bucci J,
Cozzi PJ, Kearsley JH and Li Y: PI3K/Akt/mTOR pathway inhibitors
enhance radiosensitivity in radioresistant prostate cancer cells
through inducing apoptosis, reducing autophagy, suppressing NHEJ
and HR repair pathways. Cell Death Dis. 5:e14372014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wright AA, Howitt BE, Myers AP, Dahlberg
SE, Palescandolo E, Van Hummelen P, MacConaill LE, Shoni M, Wagle
N, Jones RT, et al: Oncogenic mutations in cervical cancer: Genomic
differences between adenocarcinomas and squamous cell carcinomas of
the cervix. Cancer. 119:3776–3783. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lou H, Villagran G, Boland JF, Im KM, Polo
S, Zhou W, Odey U, Juárez-Torres E, Medina-Martínez I,
Roman-Basaure E, et al: Genome Analysis of Latin American Cervical
Cancer: Frequent activation of the PIK3CA pathway. Clin
Cancer Res. 21:5360–5370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiang L, Jiang W, Li J, Shen X, Yang W,
Yang G, Wu X and Yang H: PIK3CA mutation analysis in Chinese
patients with surgically resected cervical cancer. Sci Rep.
11:140352015. View Article : Google Scholar
|
|
11
|
Nakayama K, Takebayashi Y, Namiki T,
Tamahashi N, Nakayama S, Uchida T, Miyazaki K and Fukumoto M:
Comprehensive allelotype study of ovarian tumors of low malignant
potential: Potential differences in pathways between tumors with
and without genetic predisposition to invasive carcinoma. Int J
Cancer. 94:605–609. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jones S, Wang TL, Shih leM, Mao TL,
Nakayama K, Roden R, Glas R, Slamon D, Diaz LA Jr, Vogelstein B, et
al: Frequent mutations of chromatin remodeling gene ARID1A in
ovarian clear cell carcinoma. Science. 330:228–231. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singer G, Kurman RJ, Chang HW, Cho SK and
Shih IeM: Diverse tumorigenic pathways in ovarian serous carcinoma.
Am J Pathol. 160:1223–1228. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Singer G, Oldt R III, Cohen Y, Wang BG,
Sidransky D, Kurman RJ and Shih IeM: Mutations in BRAF and KRAS
characterize the development of low-grade ovarian serous carcinoma.
J Natl Cancer Inst. 95:484–486. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davies H, Bignell GR, Cox C, Stephens P,
Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W,
et al: Mutations of the BRAF gene in human cancer. Nature.
417:949–954. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakayama K, Nakayama N, Kurman RJ, Cope L,
Pohl G, Samuels Y, Velculescu VE, Wang TL and Shih IeM: Sequence
mutations and amplification of PIK3CA and AKT2 genes in
purified ovarian serous neoplasms. Cancer Biol Ther. 5:779–785.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakayama K, Miyazaki K, Kanzaki A,
Fukumoto M and Takebayashi Y: Expression and cisplatin sensitivity
of copper-transporting P-type adenosine triphosphatase (ATP7B) in
human solid carcinoma cell lines. Oncol Rep. 8:1285–1287. 2011.
|
|
18
|
Cancer Genome Atlas Research Network;
Albert Einstein College of Medicine; Analytical Biological
Services; Barretos Cancer Hospital; Baylor College of Medicine;
Beckman Research Institute of City of Hope; Buck Institute for
Research on Aging; Canada's Michael Smith Genome Sciences Centre;
Harvard Medical School; Helen F. Graham Cancer Center &Research
Institute at Christiana Care Health Services et al, . Integrated
genomic and molecular characterization of cervical cancer. Nature.
543:378–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yeasmin S, Nakayama K, Rahman MT, Rahman
M, Ishikawa M, Iida K, Otsuki Y, Kobayashi H, Nakayama S and
Miyazaki K: Expression of nuclear Notch3 in cervical squamous cell
carcinomas and its association with adverse clinical outcomes.
Gynecol Oncol. 117:409–416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Janku F, Lee JJ, Tsimberidou AM, Hong DS,
Naing A, Falchook GS, Fu S, Luthra R, Garrido-Laguna I and Kurzrock
R: PIK3CA mutations frequently coexist with RAS and BRAF
mutations in patients with advanced cancers. PLoS One.
6:e227692011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bertelsen BI, Steine SJ, Sandvei R, Molven
A and Laerum OD: Molecular analysis of the PI3K-AKT pathway in
uterine cervical neoplasia: Frequent PIK3CA amplification
and AKT phosphorylation. Int J Cancer. 118:1877–1883. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McIntyre JB, Wu JS, Craighead PS, Phan T,
Köbel M, Lees-Miller SP, Ghatage P, Magliocco AM and Doll CM:
PIK3CA mutational status and overall survival in patients
with cervical cancer treated with radical chemoradiotherapy.
Gynecol Oncol. 128:409–414. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim TJ, Lee JW, Song SY, Choi JJ, Choi CH,
Kim BG, Lee JH and Bae DS: Increased expression of pAKT is
associated with radiation resistance in cervical cancer. Br J
Cancer. 94:1678–1682. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Janku F, Wheler JJ, Westin SN, Moulder SL,
Naing A, Tsimberidou AM, Fu S, Falchook GS, Hong DS, Garrido-Laguna
I, et al: PI3K/AKT/mTOR inhibitors in patients with breast and
gynecologic malignancies harboring PIK3CA mutations. J Clin
Oncol. 30:777–782. 2012. View Article : Google Scholar : PubMed/NCBI
|
